CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
EASL 2015   Banner2   HighwayRx
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Gilead patents on costly hepatitis C drug challenged in 5 countries
05-20-2015
Novo Nordisk weighs diabetes drug's use in fatty liver disease
05-18-2015
Pricey new hepatitis C drugs could yield economic benefits
05-18-2015
Some cancer patients need hepatitis B virus screening before therapy
05-15-2015
View Complete News Library
 
 
July 8-11
21ST ANNUAL INTERNATIONAL CONGRESS OF THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY (ILTS)
CHICAGO, IL
September 4-6
9th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Paris, France
October 16-21
ACG 2015 Annual Scientific Meeting and Postgraduate Course
Honolulu, Hawaii
November 13-17
AASLD 2015
San Francisco, CA
View all Congresses
 
HighwayRx
 
 
 
  Line  
  Featured Abstracts          
 
Interferon-free therapy for hepatitis C: The hurdles amid a golden era
 
Increased Incidence of Cancer and Cancer-related Mortality Among Persons with Chronic Hepatitis C Infection, 2006-2010
 
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
 
Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients with Hepatitis C, Regardless of Response to Antiviral Therapy
 
Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C
 
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic HCV Genotype 1, 4, or 6 Infection: A Randomized Trial
 
 
Screening for human immunodeficiency virus and other sexually transmitted diseases among u.s. Women with prenatal care
 
Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure
 
Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
 
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
 
Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis
 
Covert hepatic encephalopathy: does the mini-mental state examination help?
 
 
Presentation and complications associated with cirrhosis of the liver
 
Branched-chain amino acids for people with hepatic encephalopathy
 
Biphenotypic hepatic tumors: imaging findings and review of literature
 
Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial
 
Elevated Alpha-Fetoprotein: Differential Diagnosis - Hepatocellular Carcinoma and Other Disorders
 
Classification and Staging of Hepatocellular Carcinoma: An Aid to Clinical Decision-Making
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.